Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

6.42
Delayed Data
As of Oct 18
 +0.23 / +3.72%
Today’s Change
1.51
Today|||52-Week Range
8.84
+214.71%
Year-to-Date

Today’s Trading

Previous close6.19
Today’s open6.28
Day’s range6.26 - 6.68
Volume3,518,925
Average volume (3 months)3,631,778
Market cap$694.6M
Dividend yield--
Data as of 10/18/2017

Growth & Valuation

Earnings growth (last year)-154.93%
Earnings growth (this year)+50.82%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-49.72%
P/E ratioNM
Price/Sales4.13
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...+0.15+1.09%
NTLAIntellia Therapeutic...-0.61-2.21%
MYOVMyovant Sciences Ltd-0.47-3.36%
CRSPCRISPR Therapeutics ...-0.51-2.79%
Data as of 10/18/2017

Financials

Next reporting dateOctober 27, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$43.0M
Annual profit (last year)-$157.8M
Net profit margin-366.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts